These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 39093726)
1. Use of sodium oxybate for the treatment of alcohol withdrawal syndrome in patients with acute alcohol-associated hepatitis: A 4-patient case report. Caputo F; Casabianca A; Brazzale C; Lungaro L; Costanzini A; Caio G; De Giorgio R; Testino G; Piscaglia F; Caraceni P Medicine (Baltimore); 2024 Aug; 103(31):e39162. PubMed ID: 39093726 [TBL] [Abstract][Full Text] [Related]
2. Diagnosis and treatment of acute alcohol intoxication and alcohol withdrawal syndrome: position paper of the Italian Society on Alcohol. Caputo F; Agabio R; Vignoli T; Patussi V; Fanucchi T; Cimarosti P; Meneguzzi C; Greco G; Rossin R; Parisi M; Mioni D; Arico' S; Palmieri VO; Zavan V; Allosio P; Balbinot P; Amendola MF; Macciò L; Renzetti D; Scafato E; Testino G Intern Emerg Med; 2019 Jan; 14(1):143-160. PubMed ID: 30187438 [TBL] [Abstract][Full Text] [Related]
3. Sodium oxybate in the treatment of alcohol withdrawal syndrome: a randomized double-blind comparative study versus oxazepam. The GATE 1 trial. Caputo F; Skala K; Mirijello A; Ferrulli A; Walter H; Lesch O; Addolorato G CNS Drugs; 2014 Aug; 28(8):743-52. PubMed ID: 24996524 [TBL] [Abstract][Full Text] [Related]
4. Clinical applications of sodium oxybate (GHB): from narcolepsy to alcohol withdrawal syndrome. Busardò FP; Kyriakou C; Napoletano S; Marinelli E; Zaami S Eur Rev Med Pharmacol Sci; 2015 Dec; 19(23):4654-63. PubMed ID: 26698265 [TBL] [Abstract][Full Text] [Related]
5. Sodium oxybate: a review of its use in alcohol withdrawal syndrome and in the maintenance of abstinence in alcohol dependence. Keating GM Clin Drug Investig; 2014 Jan; 34(1):63-80. PubMed ID: 24307430 [TBL] [Abstract][Full Text] [Related]
6. A Brief Up-Date of the Use of Sodium Oxybate for the Treatment of Alcohol Use Disorder. Caputo F; Vignoli T; Tarli C; Domenicali M; Zoli G; Bernardi M; Addolorato G Int J Environ Res Public Health; 2016 Mar; 13(3):. PubMed ID: 26959045 [TBL] [Abstract][Full Text] [Related]
7. Safety and efficacy of flumazenil for reversal of iatrogenic benzodiazepine-associated delirium toxicity during treatment of alcohol withdrawal, a retrospective review at one center. Moore PW; Donovan JW; Burkhart KK; Waskin JA; Hieger MA; Adkins AR; Wert Y; Haggerty DA; Rasimas JJ J Med Toxicol; 2014 Jun; 10(2):126-32. PubMed ID: 24619543 [TBL] [Abstract][Full Text] [Related]
8. Gamma-hydroxybutyrate (GHB) for treatment of alcohol withdrawal and prevention of relapses. Leone MA; Vigna-Taglianti F; Avanzi G; Brambilla R; Faggiano F Cochrane Database Syst Rev; 2010 Feb; (2):CD006266. PubMed ID: 20166080 [TBL] [Abstract][Full Text] [Related]
10. Gamma-hydroxybutyric acid (GHB) in the treatment of alcohol withdrawal syndrome: a randomized comparative study versus benzodiazepine. Addolorato G; Balducci G; Capristo E; Attilia ML; Taggi F; Gasbarrini G; Ceccanti M Alcohol Clin Exp Res; 1999 Oct; 23(10):1596-604. PubMed ID: 10549990 [TBL] [Abstract][Full Text] [Related]
11. Comparison of clinical outcomes in nonintubated patients with severe alcohol withdrawal syndrome treated with continuous-infusion sedatives: dexmedetomidine versus benzodiazepines. Crispo AL; Daley MJ; Pepin JL; Harford PH; Brown CV Pharmacotherapy; 2014 Sep; 34(9):910-7. PubMed ID: 24898418 [TBL] [Abstract][Full Text] [Related]
12. Identification and management of alcohol withdrawal syndrome. Mirijello A; D'Angelo C; Ferrulli A; Vassallo G; Antonelli M; Caputo F; Leggio L; Gasbarrini A; Addolorato G Drugs; 2015 Mar; 75(4):353-65. PubMed ID: 25666543 [TBL] [Abstract][Full Text] [Related]
13. The Safety and Utility of Phenobarbital Use for the Treatment of Severe Alcohol Withdrawal Syndrome in the Medical Intensive Care Unit. Oks M; Cleven KL; Healy L; Wei M; Narasimhan M; Mayo PH; Kohn N; Koenig S J Intensive Care Med; 2020 Sep; 35(9):844-850. PubMed ID: 29925291 [TBL] [Abstract][Full Text] [Related]
14. Sodium Oxybate Therapy for Alcohol Withdrawal Syndrome and Keeping of Alcohol Abstinence. Mannucci C; Pichini S; Spagnolo EV; Calapai F; Gangemi S; Navarra M; Calapai G Curr Drug Metab; 2018; 19(13):1056-1064. PubMed ID: 29219048 [TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of γ-hydroxybutyrate in treating alcohol withdrawal syndrome in an alcohol-dependent inpatient with decompensated liver cirrhosis: a case report. Caputo F; Bernardi M; Zoli G J Clin Psychopharmacol; 2011 Feb; 31(1):140-1. PubMed ID: 21192167 [No Abstract] [Full Text] [Related]
16. Sodium oxybate in the treatment of alcohol dependence: from the alcohol withdrawal syndrome to the alcohol relapse prevention. Skala K; Caputo F; Mirijello A; Vassallo G; Antonelli M; Ferrulli A; Walter H; Lesch O; Addolorato G Expert Opin Pharmacother; 2014 Feb; 15(2):245-57. PubMed ID: 24283802 [TBL] [Abstract][Full Text] [Related]
17. Phenobarbital Monotherapy for the Management of Alcohol Withdrawal Syndrome in Surgical-Trauma Patients. Ammar MA; Ammar AA; Rosen J; Kassab HS; Becher RD Ann Pharmacother; 2021 Mar; 55(3):294-302. PubMed ID: 32830517 [TBL] [Abstract][Full Text] [Related]
18. Treatment of acute alcohol withdrawal with gabapentin: results from a controlled two-center trial. Bonnet U; Banger M; Leweke FM; Specka M; Müller BW; Hashemi T; Nyhuis PW; Kutscher S; Burtscheidt W; Gastpar M J Clin Psychopharmacol; 2003 Oct; 23(5):514-9. PubMed ID: 14520131 [TBL] [Abstract][Full Text] [Related]
19. Treatment of paediatric narcolepsy with sodium oxybate: a double-blind, placebo-controlled, randomised-withdrawal multicentre study and open-label investigation. Plazzi G; Ruoff C; Lecendreux M; Dauvilliers Y; Rosen CL; Black J; Parvataneni R; Guinta D; Wang YG; Mignot E Lancet Child Adolesc Health; 2018 Jul; 2(7):483-494. PubMed ID: 30169321 [TBL] [Abstract][Full Text] [Related]
20. The effectiveness of pharmacological approaches in the treatment of alcohol withdrawal syndrome (AWS): a literature review. Cooper E; Vernon J J Psychiatr Ment Health Nurs; 2013 Sep; 20(7):601-12. PubMed ID: 22989012 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]